Briefly after touching a fresh near two-year high on Tuesday, the local bluechip benchmark dipped for profit-taking correction ahead of the Workers' Day holiday, given the short-term overbought technical momentum. The FBM KLCI shed 6.69 points to end at the day's low of 1,575.97, off an early high of 1,589.06, but gainers edged losers 524 to 521 on steady turnover of 4.18bn shares worth RM3.75bn.
The local market should extend profit-taking breather today, with market players expected to stay sidelined to assess the outcome of the US FOMC meeting regarding the path for interest rates ahead. Immediate resistance for the index is retained at 1,600, with stronger upside hurdles seen at 1,620 and then 1,640. Key supports will be at 1,553, 1,543 and 1,521, the respective rising 30-day, 50-day and 100-day moving averages.
Aemulus remains in base building mode, pending breakout above the upper Bollinger band (38sen) which is key to aim for the 38.2%FR (41sen) and 50%FR (47sen) ahead, while the 200-day ma (32sen) cushions downside risk. Unisem will need breakout confirmation above the 1/4/24 high (RM3.92) to fuel upside momentum towards the 123.6%FP (RM4.30) and 138.2%FP (RM4.54) going forward, while the 200-day ma (RM3.32) cushions downside.
Source: TA Research - 2 May 2024
Chart | Stock Name | Last | Change | Volume |
---|
2024-12-21
GAMUDA2024-12-20
GAMUDA2024-12-20
GAMUDA2024-12-20
RSAWIT2024-12-20
TROP2024-12-20
TROP2024-12-19
DPHARMA2024-12-19
F&N2024-12-19
GAMUDA2024-12-19
GAMUDA2024-12-19
GAMUDA2024-12-19
GAMUDA2024-12-19
UNISEM2024-12-19
UNISEM2024-12-19
UNISEM2024-12-18
AEMULUS2024-12-18
AEMULUS2024-12-18
F&N2024-12-18
GAMUDA2024-12-18
GAMUDA2024-12-18
RSAWIT2024-12-18
RSAWIT2024-12-18
TROP2024-12-17
DPHARMA2024-12-17
F&N2024-12-17
F&N2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
TROP2024-12-16
DPHARMA2024-12-16
F&N2024-12-16
F&N2024-12-16
F&N2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-16
TROP2024-12-13
DPHARMA2024-12-13
DPHARMA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
PHARMA2024-12-13
PHARMA2024-12-13
TROP2024-12-13
TROP2024-12-13
UNISEM2024-12-13
UNISEM2024-12-13
UNISEM2024-12-13
UNISEM2024-12-13
UNISEM2024-12-13
UNISEM2024-12-12
F&N2024-12-12
GAMUDA2024-12-12
GAMUDA2024-12-12
GAMUDA2024-12-12
GAMUDA2024-12-12
TROP2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
TROP2024-12-11
TROP2024-12-11
UNISEM2024-12-11
UNISEM2024-12-11
UNISEM2024-12-11
UNISEM2024-12-11
UNISEM2024-12-11
UNISEM2024-12-10
DPHARMA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
PHARMA2024-12-10
PHARMA2024-12-10
TROPCreated by sectoranalyst | Dec 20, 2024
Created by sectoranalyst | Dec 20, 2024
Created by sectoranalyst | Dec 20, 2024
Created by sectoranalyst | Dec 19, 2024
Created by sectoranalyst | Dec 19, 2024
Created by sectoranalyst | Dec 19, 2024